Clinical Trial Update: Investigation of A-ECM for the Correction of Soft Tissue Defects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on A-ECM for correcting soft tissue defects in the body wall region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Soft Tissue of Body Wall Region

Drugs mentioned

• A-ECM (extracellular matrix scaffold)

Snippet

Sponsor: Aegeria Soft Tissue LLC | Conditions: Disorder of Soft Tissue of Body Wall Region | Phase 1 | Status: UNKNOWN